Maximizing HCP Engagement and Field Force Reach for Pharma Launch Success

Download PDFDownload PDFTalk to UsTalk to Us

The Customer

A growing biopharmaceutical company was preparing to launch a newly approved therapy into a competitive market with a limited field organization. The company needed to engage healthcare professionals (HCPs) who had limited access to sales representatives or who were located in territories without dedicated field coverage while building awareness and driving early adoption during a critical launch period.

The client needed a scalable way to extend the reach of its commercial organization while ensuring HCPs continued to receive meaningful, personalized HCP engagement regardless of field coverage. Beyond increasing engagement, the objective was to create personalized HCP experiences that complemented field engagement in covered territories while maintaining a trusted commercial presence in vacant territories through sales leadership.

Clinician using mobile outreach to engage HCPs

The Challenges

  1. Limited field resources and vacant territories made it difficult to consistently engage priority HCPs during a critical product launch, creating gaps in commercial coverage and continuity.

  2. The client needed a scalable way to leverage the credibility of its commercial organization by delivering personalized communications from an assigned sales representative where one existed, or sales leadership where territories were vacant, creating a seamless customer experience.

  3. Marketing needed more than standard performance metrics. The client wanted to identify highly engaged HCPs, generate qualified opportunities for the commercial organization, and provide sales leadership with actionable insights to support follow-up and future field coverage.

The Solution

As part of Indegene's precision HCP engagement capabilities, BioPharm Communications, an Indegene Company, developed a precision HCP engagement strategy that transformed the commercial organization into a scalable digital engagement channel. Using the automated C.O.V.E.R. platform, the program extended personalized engagement to HCPs with limited representative access while maintaining meaningful commercial interactions in territories without dedicated field coverage.

Personalized commercial engagement

Communications were delivered on behalf of the assigned sales representative or sales leadership, depending on territory coverage, creating a consistent and trusted HCP experience.

Audience-driven journeys

Segmented engagement paths tailored messaging based on HCP needs, creating more relevant and personalized experiences.

Extended field coverage

Automated digital touchpoints enabled meaningful engagement with HCPs in both low-access and vacant territories.

Closed-loop commercial insights

Engagement activity was integrated into the client's CRM, enabling marketing-qualified leads and engagement insights to be shared with the commercial organization.

Commercial enablement

Engagement insights helped identify high-interest HCPs for representative follow-up while providing sales leadership with visibility into engagement within vacant territories.

Rather than replacing the field force, the program amplified its impact by extending trusted commercial relationships into digital channels, ensuring HCPs continued to receive meaningful engagement regardless of field coverage while generating actionable intelligence for marketing and sales.

Outcomes

The program expanded the client's commercial reach beyond the limitations of its field organization, creating meaningful engagement with HCPs across both low-access and vacant territories.

At the same time, it generated actionable engagement intelligence that helped marketing identify high-interest HCPs while enabling sales leadership to prioritize follow-up and better support territories without dedicated field coverage. The program generated 51,583 HCP engagements across 38,202 targeted HCPs, achieving a 27.5% engagement rate.

27.5%

engagement rate

38.4%

lift in prescriptions

8.7:1

return on investment

Featured Insights